Vicarious Surgical Inc.RBOTEarnings & Financial Report
NYSE
RBOT Q2 2023 Key Financial Metrics
Revenue
$-18.1M
Gross Profit
N/A
Operating Profit
$-21.5M
Net Profit
$-15.3M
Gross Margin
N/A
Operating Margin
118.3%
Net Margin
84.6%
YoY Growth
-10.9%
EPS
$-0.12
Vicarious Surgical Inc. Q2 2023 Financial Summary
Vicarious Surgical Inc. reported revenue of $-18.1M for Q2 2023, with a net profit of $-15.3M (84.6% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $-18.1M |
|---|---|
| Net Profit | $-15.3M |
| Gross Margin | N/A |
| Operating Margin | 118.3% |
| Report Period | Q2 2023 |
Income Statement
| Q2 2022 | Q2 2023 | |
|---|---|---|
| Revenue | $-16.3M | $-18.1M |
| YoY Growth | N/A | -10.9% |
Balance Sheet
| Q2 2022 | Q2 2023 | |
|---|---|---|
| Assets | $164.1M | $104.5M |
| Liabilities | $34.3M | $28.8M |
| Equity | $129.8M | $75.7M |
Cash Flow
| Q2 2022 | Q2 2023 | |
|---|---|---|
| Operating CF | $-14.2M | $-15.1M |